Cleared Traditional

K933816 - SONICAID MODEL P110 FETAL HEAR DETECTOR

K933816 is an FDA 510(k) clearance for SONICAID MODEL P110 FETAL HEAR DETECTOR, manufactured by Oxford Instruments, Plc.. The device is a Class 2 Obstetrics & Gynecology device with product code HEL cleared through the Traditional 510(k) pathway after a 505-day FDA review.

K933816 · Oxford Instruments, Plc. · Obstetrics & Gynecology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1994
Decision
505d
Days
Class 2
Risk

K933816 is an FDA 510(k) clearance for the SONICAID MODEL P110 FETAL HEAR DETECTOR. Classified as Monitor, Heart Rate, Fetal, Ultrasonic (product code HEL), Class II - Special Controls.

Submitted by Oxford Instruments, Plc. (Clearwater, US). The FDA issued a Cleared decision on December 22, 1994 after a review of 505 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.2660 - the FDA obstetrics and gynecology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Obstetrics & Gynecology submissions.

View all Oxford Instruments, Plc. devices

FDA 510(k) Submission Details - K933816

510(k) Number K933816 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 04, 1993
Decision Date December 22, 1994
Days to Decision 505 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
345d slower than avg
Panel avg: 160d · This submission: 505d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HEL Device Classification - Class 2, Special Controls

Product Code HEL Monitor, Heart Rate, Fetal, Ultrasonic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 884.2660
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Obstetrics & Gynecology devices follow this clearance model.